An international, multicenter, randomized, double-blind, placebo-controlled Phase III trial investigating the efficacy and safety of rivaroxaban to reduce the risk of major thrombotic vascular events in patients with symptomatic peripheral artery disease undergoing lower extremity revascularization procedures


A prospective, multicenter Phase III study, confirming the superior effectiveness of the ELUVIA stent versus self-expanding Bare Nitinol Stents in the treatment of lesions in the femoropopliteal arteries.


A prospective, international, multi-center, single arm, non- interventional study to continue to assess the treatment by the Stellarex Balloon in superficial femoral and/or popliteal arteries according to the instructions for use in a broad, real-world, claudicant or ischemic rest pain patients population per the institution’s standard practice.